Your browser doesn't support javascript.
loading
Successful long-term outcome after combined hematopoietic stem cell transplantation and small bowel transplantation: A case report and review of the literature.
Na, Sera; Saldana, Blachy Davila; Peredo-Pinto, Helka; Gonzalez, Corina Elena; Kroemer, Alexander Helmut; Hawksworth, Jason; Matsumoto, Cal Satoshi; Yazigi, Nada; Kaufman, Stuart; Fishbein, Thomas Marlon; Khan, Khalid.
Afiliação
  • Na S; Department of Pediatrics, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Saldana BD; Department of Pediatric Hematology/Oncology, Children's National Medical Center, Washington, DC, USA.
  • Peredo-Pinto H; Department of Pediatric Hematology/Oncology, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Gonzalez CE; Department of Pediatric Hematology/Oncology, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Kroemer AH; Transplant Surgery, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Hawksworth J; Transplant Surgery, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Matsumoto CS; Transplant Surgery, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Yazigi N; Department of Transplant, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Kaufman S; Department of Transplant, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Fishbein TM; Transplant Surgery, Medstar Georgetown University Hospital, Washington, DC, USA.
  • Khan K; Department of Transplant, Medstar Georgetown University Hospital, Washington, DC, USA.
Pediatr Transplant ; 23(7): e13563, 2019 11.
Article em En | MEDLINE | ID: mdl-31471935
ABSTRACT
Combining HSCT with SOT is an unusual and challenging undertaking given the complexities of immune modulation, the need to balance comorbidities, and the cumulative potential for complications. Early life-threatening complications include infections and related effects, graft rejection, and GVHD can be expected to be increased especially if the HSCT is indicated for high-risk cases such as individuals with severe combined immune deficiency and SOT that includes an intestine graft. Herein, we report such a case. Our patient is unique as a long-term survivor. We review the literature and the features of our case, especially the timing of transplants and human leukocyte antigen matching for HSCT that resulted in a successful outcome and discuss how this may be applied to others in the future.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa / Transplante de Células-Tronco Hematopoéticas / Intestino Delgado Limite: Child / Child, preschool / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Transplant Assunto da revista: PEDIATRIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa / Transplante de Células-Tronco Hematopoéticas / Intestino Delgado Limite: Child / Child, preschool / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Transplant Assunto da revista: PEDIATRIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos